Large-scale selection of CD34+ peripheral blood progenitors and expansion of neutrophil precursors for clinical applications

Journal of Hematotherapy and Stem Cell Research

Volumn 5, Issue 3, 1996, Pages 247-253

  Zimmerman, Todd M ^a   Bender, James G ^b   Lee, Wanda J ^b   Loudovaris, Maureen ^b   Qiao, Xiaoying ^b   Schilling, Marta ^b   Smith, Stephen L ^b   Unverzagt, Kristen ^b   Van Epps, Dennis E ^b   Blake, Mary ^a   Williams, Douglas F ^c   Williams, Stephanie F ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b BAXTER HEALTHCARE CORPORATION   (United States)

^c AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD15 ANTIGEN; CD34 ANTIGEN; CYCLOPHOSPHAMIDE; HUMAN SERUM ALBUMIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CELL SELECTION; CELL SEPARATION; CELL VIABILITY; COLONY FORMING UNIT; COLONY FORMING UNIT GM; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; MEGAKARYOCYTE; NEUTROPHIL; PRIORITY JOURNAL;

ADULT; ANTIGENS, CD34; CELL SEPARATION; CELLS, CULTURED; FLOW CYTOMETRY; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HEMATOPOIESIS; HUMANS; INTERLEUKIN-3; NEUTROPENIA; NEUTROPHILS; RECOMBINANT FUSION PROTEINS; STEM CELLS;

EID: 0029758660     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.1.1996.5.247     Document Type: Article

References (19)

1. Brandt, S.J., Peters, W.P., Atwater, S.K., et al. Effect of recombinant human granulocyte macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous stem cell rescue. N. Engl. J. Med. 318:867, 1988.
2. Sheridan, W.P., Begley, C.G., Juttner, C.A., et al. Effect of peripheral blood progenitors mobilised by filgrastim (G-CSF) on platelet recovery after high-dose chemotherapy. Lancet 339:640, 1993.
3. Zimmerman, T.M., Williams, R.M., Myers, S., et al. Source of stem cell progenitors impacts upon hematopoietic recovery after high-dose chemotherapy. In Molecular Biology of Hematopoiesis III, eds. Abraham, N.G., Shadduck, R.K. & Takaku, F. Intercept, Andover, UK, 1994, p. 231.
4. Bender, J.G., To, L.B., Williams, S.F., et al. Defining a therapeutic dose of peripheral blood stem cells. J. Hematotherapy 1:329, 1992.
5. Siena, S., Bregni, M., Brando, B., et al. Flow cytometry for clinical estimation of circulating hematopoietic progenitors for autologous transplantation in cancer patients. Blood 77:400, 1991.
6. Jones, R.J., Celano, P., Sharkis, S.J., et al. Two phases of engraftment established by serial bone marrow transplantation in mice. Blood 73:397, 1989.
7. Haylock, D.N., To, L.B., Dowse, T.L., et al. Ex vivo expansion and maturation of peripheral blood CD34+ cells into the myeloid lineage. Blood 80:1405, 1992.
8. Koller, M.R., Emerson, S.G. & Palsson, B.O. Large-scale expansion of human stem and progenitor cells from bone marrow mononuclear cells in continuous perfusion cultures. Blood 82:378, 1993.
9. Smith, S.L., Bender, J.G., Maples, P.B., et al. Expansion of neutrophil precursors and progenitors in suspension cultures of CD34+ cells enriched from human bone marrow. Exp. Hematol. 21:870, 1993.
10. Bender, J.G., Unverzagt, K. & Walker, D. Determination of CD34+ cells by flow cytometry: Application to the harvesting and transplantation of peripheral blood stem cells. In Hematopoietic Stem Cells: The Mulhouse Manual, eds. Wunder, E., Sovalat, H., Henon, P.R. & Serke, S. Alpha Med Press, Dayton, OH, 1994.
11. Qiao, X., Loudovaris, M., Unverzagt, K., et al. Immunocytochemistry and flow cytometry evaluation of human megakaryocytes in fresh samples and culture of CD34+ cells. Cytometry 23:250, 1996.
12. Shpall, E.J., Jones, R.J., Bearman, S.I., et al. Transplantation of enriched CD34-positive autologous marrow in breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J. Clin. Oncol. 12:28, 1994.
13. Shapiro, F., Yao, T.J., Raptis, G., et al. Optimization of conditions for ex vivo expansion of CD34+ cells from patients with stage IV breast cancer. Blood 84:3567, 1994.
14. Williams, D.E. & Park, L.E. Hematopoietic effects of a granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein. Cancer 67:2705, 1991.
15. Otsuka, T., Thacker, J.D. & Hogge, D.E. The effects of interleukin-6 and interleukin-3 on early hematopoietic progenitors in long-term cultures of human marrow. Exp. Hematol. 19:1042, 1991.
16. Henschler, R., Brugger, W., Luft, T., et al. Maintenance of transplantation potential in ex vivo expanded CD34+ selected human peripheral blood progenitor cells. Blood 84:2898, 1994.
17. Koller, M.R., Bender, J.G., Miller, W.M., et al. Expansion of human hematopoietic progenitors in a perfusion bioreactor system with IL-3, IL-6, and stem cell factor. Biotechnology 11:358, 1993.
18. Brugger, W., Heimfeld, S., Berenson, R.J., et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitors generated ex vivo. N. Engl. J. Med. 333:283, 1995.
19. Gluck, S., Chadderton, T., Porter, K., et al. Characterization and transfusion of in vitro cultivated hematopoietic progenitor cells. Transfus. Sci. 16:273, 1995.